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Negative Pressure Wound Therapy (NPWT) is commonly used in many surgical specialties to improve
wound management and healing outcomes. This study reports the ability of gauze-based NPWT to
address several treatment goals commonly deﬁned at the onset of therapy. A prospective, multi-center,
non-comparative clinical investigation was carried out using gauze-based NPWT in chronic and acute
wounds. 131 patients including traumatic, post-surgical and chronic wounds were assessed. Weekly
percentage reductions in wound area, depth and volume were 8.3%, 15.8% and 20.5% respectively
(p < 0.001). A reduction in exudate level was observed from baseline to treatment discontinuation
(p < 0.001). An increase (p ¼ 0.007) in red granulation tissue and a decrease (p < 0.001) in non-viable
tissue was observed. Baseline wound characteristics associated with slower rates of progress included
chronic wound aetiologies, longer wound duration prior to NPWT and presence of diabetes as a co-
morbidity. Important indicators of wounds which had improved sufﬁciently and no longer required
NPWT included reduction in volume and exudate levels. Gauze-based NPWT can be used to address
many of the treatment goals commonly deﬁned at the onset of therapy including reduction in wound
volume, management of exudate and infection status, and improvement in wound bed quality.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Negative Pressure Wound Therapy (NPWT) is an increasingly
widespread adjunctive therapy in the treatment of challenging
wounds and has been shown to contribute to post-surgical wound
management in several ways. NPWT has been shown to reduce
wound dimensions potentially leading to reduced complexity of
surgical closure1 and to act as a ‘bridge’ to manage the wound until
surgical closure is possible.2 Gauze-based NPWT has recently been
rediscovered. Early clinical investigations have shown it is clinically
efﬁcacious3,4 and may provide a viable alternative to foam-based
NPWT. Furthermore, it has been suggested that gauze may provide
a less painful option compared to foam-based NPWT during
dressing changes as tissue does not grow into the gauze as has been
commonly observed with foam.5ax: þ44 1482 673 307.
(J. Smith).
ciates Ltd. Published by Elsevier LtAlthough questions remain regarding the relative efﬁcacy of
foam and gauze-based NPWT, evidence is emerging to suggest
great similarities can be observed between the two wound inter-
face materials. In vivowork has shown several aspects of NPWT are
equivalent through either foam or gauze. Tissue contraction and
changes in microvascular ﬂow occur to a similar degree on initia-
tion of negative pressure.6,7 Recent computer modeling also
predicts surface stimulation due to micro-deformation of wound
tissue with both foam and gauze.8 A comparative study between
foam-based and gauze-based NPWT recently demonstrated no
signiﬁcant differences between the two groups in clinical efﬁcacy.5
A signiﬁcant difference in favor of gauze-based NPWTwas however
observed with pain experienced during and after dressing changes
much lower in the gauze-based NPWTcompared to the foam-based
NPWT group.5
It is increasingly recognized that NPWT can be used to achieve
a variety of treatment goals which will vary according to the patient
and wound characteristics. The advent of NPWT has introduced thed. All rights reserved.
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may act as staging posts along the path towards complete closure
which are in themselves useful end-points in any clinical trial.
These include a reduction in wound dimensions (area, depth and
volume), an increase in granulation tissue and a decrease in non-
viable tissue, and exudate and infection management. In clinical
practice there comes a point for the majority of NPWT-treated
wounds, when the wound has improved considerably and can be
managed using alternativemethods of woundmanagement such as
surgical closure techniques or advanced dressings. Not only does
this have implications for the efﬁciency of wound healing but also
on the cost of healing. When making a decision to stop NPWT,
a clinician must determine whether the initial objectives or goals of
therapy have been achieved. If so, it must be considered whether
any further beneﬁt can be achieved through the continued use of
NPWT, or whether transfer to an alternative method of wound
management may be more appropriate. However, there is no
published data available to describe the degree of improvement
which should be observed before NPWT can be stopped and the
wound can be managed by alternative methods of wound
management. The aims of this evaluationwere to report the clinical
outcomes of gauze-based NPWT and the degree of improvement of
a wound before it is considered clinically appropriate to stop NPWT
and switch onto alternative methods of wound management.2. Methods
2.1. Study design
A prospective, non-comparative multi-center evaluation was carried out to
assess the performance of gauze-based NPWT in wounds deemed suitable for
treatment with NPWT. The primary objective was to assess wound progress towards
closure by measuring three clinical variables; granulation tissue formation, exudate
management and reduction in wound dimensions. The study was performed in
accordance with guidelines set forth by the Declaration of Helsinki and subsequent
revisions. The study was approved by the Ethical Review Boards at all involved
institutions and all patients provided informed consent prior to enrollment.
Exclusion criteria included the presence of >25% necrotic tissue in the wound bed,
untreated osteomyelitis, malignancy, active bleeding, exposed blood vessels or
organs and untreated infection in the wound. All wounds suitable for NPWT (as
determined by the list of clinical indications available for the chosen apparatus)
were screened against the inclusion and exclusion criteria. Wounds which had
received NPWTas an adjunct to split-thickness skin graft (STSG) were excluded from
the following analysis and will be described separately elsewhere.Table 1
Patient demographics.
Wound type N (%) Median wound duration
prior to therapy in weeks
(range)
Chronic
Diabetic Foot Ulcer 15 (11) 17 (3e364)
Venous Leg ulcer 4 (3) 41 (13e104)2.2. Clinical procedures and outcomes
NPWT was delivered using either EZ-Care or V1STA devices (Smith & Nephew,
Largo, FL) at a continuous negative pressure of 80 mmHg. The wound ﬁller used
was saline-moistened gauze (Kerlix-AMD; Tyco, Gosport, UK) provided as part of the
dressing kit and applied to the wound using the Chariker-Jeter method of applica-
tion.9 Wounds were assessed, photographs taken and dressings changed typically
every 3 days. The following parameters were measured: wound area, depth and
volume (a function of area and depth); exudate levels (using a 4 point category
scoring system - none, mild, moderate or heavy) and wound bed tissue (measured
by recording the percentage area of thewound surface composed of red granulation,
yellow slough, yellow ﬁbrous, black necrotic, pink epithelial and other).
“Treatment discontinuation” was deﬁned as the point at which the attending
physician judged that the wound had progressed sufﬁciently to no longer require
NPWT. Reasons for treatment discontinuation were captured. For the purposes of
this study, therapy could continue for no more than 30 days or 10 dressing changes
(whichever occurred ﬁrst). A single follow-up assessment was carried out 7 days
following discontinuation of therapy.Pressure ulcer 34 (26) 13 (2e156)
Acute
Post-surgical 63 (48) 3 (0e312)
Traumatic 12 (9) 2 (0e52)
Other 3 (2) 4 (1e9)
Overall 131 7.3
Male (%) 53
Mean age (range) 60.5 (22e92)2.3. Data assessment and statistical evaluation
The Wilcoxon-Signed Rank test was used to test for changes in the reference
wound area, depth and volume, the percentage of red granulation tissue and the
percentage of non-viable tissue from baseline to treatment discontinuation. The
Cochran-Mantel-Haenszel test stratiﬁed by patient, was used to assess changes in
exudate level.3. Results
3.1. Wound and patient demographics
In total 152 eligible patients were recruited. Data relating to 131
patients is described in this report. The remaining 21 patients all
received gauze-based NPWT on top of a split-thickness skin graft
and data relating to these patients will be reported elsewhere as
STSG represent a different treatment goal with different end-
points. 21% (26) patients were withdrawn early from the study due
to poor compliance (5), lack of clinical response (2), patients’ own
request (1), lost to follow-up mostly due to transfer into other care
settings where NPWT was not available (9), death (unrelated to
NPWT) (2) and other reasons (5). Two further patients were
withdrawn due to product complaints (inability to create a seal due
to the anatomical position of the wound). Evaluable data was
recorded for all withdrawn patients and was included in all anal-
yses. Patient demographics are described in Table 1. Brieﬂy, 53% of
patients were male, mean age was 60.5 (ranging from 22 to 92).
Wound etiology was mixed and included chronic wounds (40%)
and acute wounds including traumatic and post-surgical wounds
(60%). 3 acute wounds did not ﬁt within the traumatic or post-
surgical categories and were classiﬁed as ‘other’ (Calciphylaxis
secondary to end stage renal disease, bullae from septic ankle
arthritis and post-debridement burn). Mean wound duration prior
to therapy was 7.3 weeks.Effect of gauze-based NPWT on clinical outcomes
All wound dimensions (area, depth and volume) were signiﬁ-
cantly reduced (p < 0.001) during gauze-based NPWT (Table 3)
with median percentage reductions of 33%, 50% and 66% respec-
tively. The reductions in wound area, depth and volume per week
were 8%, 16% and 20.5% per week respectively (Table 2).
There was a signiﬁcant reduction (p < 0.001) in wound exudate
levels from baseline to treatment discontinuation (Fig. 1). The
number of wounds with no exudate increased from 11 (8.5%) at
baseline to 44 (33.8%) at therapy discontinuation. At baseline, 19
(14.6%) patients had heavily exuding wounds - this was reduced to
2 (1.5%) at therapy discontinuation. Despite high exudate levels
both of these wounds were classed as “progressing towards
healing”.
The ability of gauze-based NPWT to increase the amount of
granulation tissue was also assessed (Fig. 2). There was a signiﬁcant
increase (p ¼ 0.007) in the percentage area of the wound bed
composed of red granulation tissue increasing from 80% at baseline
to 90% at treatment discontinuation. There was also a signiﬁcant
reduction (p < 0.001) in the percentage of non-viable tissue
Table 2
Changes in wound dimensions following gauze-based NPWT. Wound dimensions were measured at the onset of NPWT and at the end of therapy (immediately following
discontinuation of the therapy). Overall median percentage reductions inwound size from initial measurements were calculated. Statistical signiﬁcance of the reduction in size
was calculated compared with the baseline measurement. Calculations of the percentage reduction in wound dimensions per week are also shown.
n Wound dimensions Overall reduction Weekly reduction
Baseline (range) End (range) % P value %
Wound area 126a 19.2 cm2 (1e589) 11.8 cm2 (0e298.5) 32.7 <0.001 8.3
Wound depth 121b 2 cm (0.2e18) 0.8 cm (0e6.8) 50 <0.001 15.8
Wound volume 120c 40.2 cm3 (1e3141.6) 7.4 cm3 (0e452.4) 66.3 <0.001 20.5
a No record of wound area at either baseline or end of therapy or both in 5 patients.
b Wound depth was not recorded either at baseline or end of therapy in 6 patients, a further 4 patients had a baseline wound depth of 0 and %reduction could therefore not
be calculated.
c As wound volume was a function of area and depth, volume data was not calculable in 11 patients.
R. Dunn et al. / International Journal of Surgery 9 (2011) 258e262260
ORIGINAL RESEARCH(cumulative values of necrotic, slough and ﬁbrotic tissue types) in
the wound bed reducing from 20% at baseline to 0% at treatment
discontinuation.
The study protocol was designed to allow participating clini-
cians to decide when it was clinically appropriate to stop NPWT.
Median treatment durationwas 19.5 days (Table 3). The reasons for
discontinuation of NPWT were captured; 14% of patients’ wounds
achieved healing/closure; 40% achieved ‘sufﬁcient progress’ in the
wound leading to a change in treatment from gauze-based NPWT
to alternative methods of wound management (e.g. advanced
wound dressings or surgical closure). This was considered a posi-
tive outcome. 25% reached the end of the maximum 30 days
treatment regime. A sub-analysis showed that 90% of these patients
were progressing towards healing at therapy discontinuation (data
not shown). 21% (26) patients were withdrawn from the study for
reasons stated above.
Anattemptwasmade tounderstandwhetherbaselinewoundand
patient characteristics affected the subsequent efﬁcacy of gauze-
basedNPWT. A sub-analysiswas carried out to investigate keyclinical
outcomes (time to achieve ‘sufﬁcient progress’ and changes inwound
dimensions) in light of baseline wound characteristics. Brieﬂy, the
following factors were associated with longer duration of NPWT
required to reach ‘sufﬁcient progress’ and less marked weekly
reduction inwound volume: chronic wound etiology (as opposed to
acute), longer duration of wound prior to initiation of therapy, and
presence of diabetes as a co-morbidity (Fig. 3).Fig. 1. Reduction in level of exudate following gauze-based NPWT. Exudate levels were
recorded at baseline and at discontinuation of therapy. A shift from high and moderate
exuding wounds towards low exuding wounds was observed throughout the course of
gauze-based NPWT. N ¼ 130 (Data from 1 patient not recorded).An attempt was made to identify key features of wounds which
were deemed to have made sufﬁcient progress by comparison
with those which required further NPWT (Table 4). Wounds which
had healed or had been transferred onto other less intensive
therapies within the 30 day study period were considered to have
made ‘sufﬁcient progress’. Wounds which were still receiving
NPWT at the end of the 30 day study period and those that were
withdrawn early from the evaluation were categorized as
‘requiring further NPWT’.
Wounds that achieved ‘sufﬁcient progress‘ showed a greater
reduction in wound area, depth and volume thanwounds ‘requiring
further therapy’ (Table 4). In wounds which had achieved ‘sufﬁcient
progress’, a relatively modest reduction of wound area of only 44%
compared to baseline was observed. In comparison, reduction in
wound volume was much more pronounced at 86% reduction
compared to baseline. Furthermore there was a marked reduction in
exudate levels in thewoundswhichhad achieved ‘sufﬁcientprogress’
compared with those that required further NPWT. At therapy
discontinuation, 36 (54%) wounds which had achieved ‘sufﬁcient
progress’ were reported to have no exudate compared with only 6
(10.7%) wounds ‘requiring further NPWT’. The median % red granu-
lation tissue and non-viable tissue was however similar for wounds
that made sufﬁcient progress and wounds ‘requiring further NPWT’
(Table 4).Fig. 2. Increase in granulation tissue and decrease in non-viable tissue in wounds
treated with gauze-based NPWT. Percentage wound area consisting of non-viable
(necrotic, slough and ﬁbrous tissue), granulation tissue (red tissue in the wound bed)
and epithelial tissue was assessed at baseline (left hand side) and at treatment
discontinuation (right hand side). Within each box, the horizontal line is the median
and the cross indicates the mean. The box indicates the interquartile range, and the
cut-off lines above and below extend 1.5 times the interquartile range from the 25th or
75th percentile rolled back to where there are data. Those patients who lie outside this
distance are represented by a square (outliers) N ¼ 129.
Table 3
Reason for Treatment discontinuation and therapy duration. Median duration of
therapy was 19.5 days.
Reason for discontinuation of therapy Number (%) of patients
Wound Healed 17 (13.7)
Sufﬁcient progress (switch to less
intensive therapies)
50 (40.3)
End of 30 days treatment regime 31 (25.0)
Withdrawn 26 (21.0)
Overall 124a (100)
a The reason for treatment discontinuation was not given in 7 patients.
Table 4
Differences in Outcomes between wounds making sufﬁcient progress leading to
a change in treatment and wounds requiring further NPWT. ‘Sufﬁcient progress’was
deﬁned as where wound progress was sufﬁcient to allow transfer to a different
treatment regime (e.g. surgical closure or conventional wound dressings). Wounds
which did not reach this milestone during the course of the study were labeled
‘requiring further NPWT’. All wounds were included into one of two groups. Full
data set was not available for all patients. Changes inwound dimensions, appearance
of the wound bed and exudate levels were assessed for each group and data pre-







 % Area reduction 44% (n ¼ 64) 21% (n ¼ 55)
 % Depth reduction 67% (n ¼ 61) 33% (n ¼ 54)
 % Volume reduction 86% (n ¼ 60) 55% (n ¼ 54)
Appearance of wound bed
 % Granulation tissue 90% (n ¼ 66) 92.5% (56)
 % Non-viable tissue 0% (n ¼ 66) 0% (56)
Exudate levels
 None 36 (53.7%) 6 (10.7%)
 Mild 26 (38.8%) 37 (66.1%)
 Moderate 4 (6.0%) 12 (21.4%)
 Heavy 1 (1.5%) 1 (1.8%)
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Patients from a variety of surgical specialties were recruited into
this study. The values in the present study compare well with
previous published studies relating to the use of both gauze-based
and foam-based NPWT. Other studies reporting outcomes of both
foam,10,11 and gauze3-based NPWT on mixed population wounds
progressed by secondary intention show comparable results. A
signiﬁcant increase in the amount of granulation tissue and
a signiﬁcant decrease in the amount of non-viable tissue was
observed in this study indicating that gauze-based NPWT is capable
of inducing granulation tissue formation. The relatively high level
of granulation tissue measured at the onset of therapy of 80% could
be partially due to the fact that 41% of wounds were debrided prior
to the ﬁrst application of NPWT potentially revealing red tissue in
the wound bed beneath non-viable tissue. This red tissue in the
debrided wounds may have been composed of other ‘red’ tissues
e.g. freshly debrided muscle and not granulation tissue as recorded.
This may have artiﬁcially increased the overall recorded median
percentage of granulation tissue. The ability of NPWT to induce
granulation tissue formation faster than conventional therapy is
a well accepted phenomenon and has been demonstrated in 3
randomized controlled trials on foam-based NPWT.12e14
When making a decision to stop NPWT, a clinician must
determine whether the initial objectives or goals of therapy have
been achieved. If so, it must be considered whether any further
beneﬁt can be achieved through the continued use of NPWT, or
whether transfer to an alternative method of wound management
may be more appropriate. However there is a current lack of
published information that attempts to describe the characteris-
tics of wounds which have achieved ‘sufﬁcient progress’. ‘Sufﬁ-
cient progress’ was recorded in this study as a way of recognizing
that clinicians do not always use NPWT to closure but often as
a bridging technique, until alternative methods of woundFig. 3. Effect of wound characteristics on clinical outcomes. Time to achieve sufﬁcient prog
Meier analysis (A). Median % reductions in volume per week were calculated within each c
included, pressure ulcers, leg ulcers and diabetic foot ulcers) and not according to wound du
trauma wounds. Overall median time to achieve ‘sufﬁcient progress’ of 19.5 days (A) and %management such as surgical closure become appropriate.15 A
question remains; what features characterize a wound which has
progressed sufﬁciently and no longer requires NPWT? In an
attempt to answer the question, characteristics of wounds which
achieved sufﬁcient progress were identiﬁed by comparing with
those wounds which did not reach this level of progression (Table
4). The percentage coverage of granulation tissue was equally high
in both groups suggesting that a high degree of granulation tissue
by itself may not provide sufﬁcient reason to discontinue NPWT. A
difference in wound dimensions was observed between the two
groups, demonstrating that a signiﬁcant reduction in wound
volume and depth in particular may be key drivers in the decision
to stop NPWT and progress onto alternative methods of wound
management. This is supported by two independent randomized
controlled trials which identiﬁed that wound depth was the
dimension most signiﬁcantly reduced by (foam-based) NPWT.11,16
A signiﬁcant reduction in area appeared to be less important in
determining when to stop NPWT - wounds which were judged to
have made sufﬁcient progress had only reduced by a relatively
modest 44%. A clear differential also existed with regard to
exudate levels - wounds judged to have made sufﬁcient progress
had a more pronounced shift towards low or no exudate. Oneress within each category (etiology, duration, diabetes) was estimated using a Kaplan
ategory (B). Wound chronicity was determined according to etiology (chronic wounds
ration. Acute classiﬁcation included all other wound etiologies, principally surgical and
weekly reduction in volume (B) are denoted by the horizontal dotted lines.
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treatment goal at onset of therapy was not recorded. It is likely
that achievement of the original treatment goal will be clearly
linked with the decision that NPWT is no longer required and
progress to an alternative therapy. Furthermore it appears that
certain factors may inﬂuence the rapidity of the wound response
to NPWT, with chronic wound types, those with longer wound
durations and diabetes as a co-morbidity speciﬁcally impacting on
the required duration of NPWT as well as the weekly reduction in
wound volume. It may be important to recognize that in patients
with these confounding factors, longer duration of NPWT to ach-
ieve the desirable goals may be required. The observations
reported here may also be strengthened by future comparative
studies, speciﬁcally those which investigate the impact of initial
treatment goals on the decision of when to stop NPWT, and the
impact of patient characteristics on the outcomes of NPWT. It is
hoped that this evidence can provide food for thought to clinicians
to consider when the appropriate time has been reached to stop
NPWT therapy and switch to an alternative form of wound
management such as advanced wound dressings according to
their clinical judgment.
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